[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Insight Molecular Diagnostics Inc (IMDX)

Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 185,345
  • Shares Outstanding, K 32,290
  • Annual Sales, $ 4,060 K
  • Annual Income, $ -50,220 K
  • EBIT $ -49 M
  • EBITDA $ -47 M
  • 60-Month Beta 1.76
  • Price/Sales 45.31
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 272.60% (-53.72%)
  • Historical Volatility 90.64%
  • IV Percentile 20%
  • IV Rank 19.90%
  • IV High 1,191.63% on 03/11/26
  • IV Low 44.23% on 03/12/26
  • Expected Move (DTE 10) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 28
  • Volume Avg (30-Day) 23
  • Put/Call OI Ratio 0.52
  • Today's Open Interest 468
  • Open Int (30-Day) 968
  • Expected Range 5.64 to 5.64

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $0.48
  • Growth Rate Est. (year over year) +208,025.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.55 +23.96%
on 06/18/26
6.25 -9.76%
on 06/09/26
+0.40 (+7.63%)
since 06/05/26
3-Month
2.64 +113.23%
on 04/10/26
6.86 -17.78%
on 05/18/26
+2.27 (+67.36%)
since 04/06/26
52-Week
2.33 +142.06%
on 08/29/25
8.51 -33.73%
on 11/12/25
+2.79 (+97.89%)
since 07/03/25

Most Recent Stories

More News
Insight Molecular Diagnostics: Q1 Earnings Snapshot

Insight Molecular Diagnostics: Q1 Earnings Snapshot

IMDX : 5.64 (-1.74%)
Insight Molecular Diagnostics: Q4 Earnings Snapshot

Insight Molecular Diagnostics: Q4 Earnings Snapshot

IMDX : 5.64 (-1.74%)
This Biotech Stock Is Up 158% in a Year. What’s Driving It Higher?

Insight Molecular Diagnostics (IMDX) is a precision diagnostics company with disruptive transplant technology and strong recent price momentum. IMDX has surged 158% over the past year and is trading at...

IMDX : 5.64 (-1.74%)
Insight Molecular Diagnostics: Q3 Earnings Snapshot

Insight Molecular Diagnostics: Q3 Earnings Snapshot

IMDX : 5.64 (-1.74%)
Insight Molecular Diagnostics (IMDX) Gets a Buy from Lake Street

In a report released today, Thomas Flaten from Lake Street maintained a Buy rating on Insight Molecular Diagnostics, with a price target of $8.00. The company’s shares closed last Friday at $3.35.Elevate...

IMDX : 5.64 (-1.74%)
Insight Molecular Diagnostics Extends Executive Employment Agreement

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Insight Molecular...

IMDX : 5.64 (-1.74%)
Insight Molecular Diagnostics: Q2 Earnings Snapshot

Insight Molecular Diagnostics: Q2 Earnings Snapshot

IMDX : 5.64 (-1.74%)

Business Summary

Insight Molecular Diagnostics Inc. is a pioneering diagnostics technology company. Insight Molecular Diagnostics Inc., formerly known as Oncocyte Corporation, is based in NASHVILLE, Tenn.

See More

Key Turning Points

3rd Resistance Point 6.37
2nd Resistance Point 6.20
1st Resistance Point 5.92
Last Price 5.64
1st Support Level 5.47
2nd Support Level 5.30
3rd Support Level 5.02

See More

52-Week High 8.51
Fibonacci 61.8% 6.15
Last Price 5.64
Fibonacci 50% 5.42
Fibonacci 38.2% 4.69
52-Week Low 2.33

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.